The nootropic concept and dyslexia

A review is presented of controlled studies using intensive teaching intervention to improve dyslexics' reading ability. The results of eight controlled studies reveal only one showing the superiority of teaching. Taking this as a background, the work on Nootropics is reviewed. Both animal and clinical work with Piracetam (the first of the Nootropics) seems to indicate that this medication lacks significant or serious side effects and appears to promote memory and learning. Many double-blind studies of Piracetam have now been conducted on dyslexic children. These studies suggest that Piracetam improves the reading ability of dyslexics. In addition electrophysiological studies support the notion that Piracetam may be "left hemisphere active." Such encouraging trends will doubtless lead to further research in this interesting area.